AbstractBackgroundPneumococcal vaccination for children was introduced in Sweden in 2009. For more than two decades, previous studies have shown that anesthetic cream Emla® has good effect in reducing vaccine-related pain. Even today health care workers claim “children forget quickly, and it (the pain) goes away”, this ignorance causes pain in children not treated or treated in one for the child and his guardians satisfactorily way.PurposeThe purpose of this intervention study was to compare the effect of Emla® cream for pain relief or no pain relief in connection with the first pneumococcal vaccination at three months of age in child healthcare.MethodThe study included 72 children who, at three months of age received their first pneumococcal vaccine (Prevenar 13®). The children were randomized, 36 children received pneumococcal vaccination with placebo cream and the other 36 children received the intervention, Emla®-cream.ResultThe result shows that anesthetic cream Emla® significantly reduces pain when FLACC is used as a pain assessment tool and the children begin to cry significantly later than children who received placebo cream. An interesting secondary finding of the study was that the younger the child was the stronger was the reaction to pain.ConclusionThe infant needs to be treated as an autonomous individual with full integrity. We recommend Emla® to be used and applied in vaccination when the children are three-, five- and twelve months.
Scandinavian Journal of Pain – de Gruyter
Published: Dec 29, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera